Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Non-viral Drug Delivery Systems Market, focused on intracellular technologies and biologics, is projected to grow at an annualized rate of ~14%, during the period 2022-2035, claims Roots Analysis

This image opens in the lightbox

News provided by

Roots Analysis

20 Apr, 2023, 14:45 GMT

Share this article

Share toX

Share this article

Share toX

The growing demand for novel drugs, which hold potential for the treatment of previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery systems that facilitate intracellular transport of such therapeutics across the cytosol.

LONDON, April 20, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Non-Viral Drug Delivery / Intracellular Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035" report to its list of offerings.

In contemporary healthcare, targeted therapeutics have gained significant attention, prompting the need for robust drug delivery technologies that can effectively address issues of cytotoxicity, sustained delivery, and blood-brain barrier penetration. Non-viral drug delivery systems, including cell-penetrating peptides, nanoparticles and liposomes, are being employed as viable options to overcome these challenges.

To order this 235 page report, which features 90+ figures and 120+ tables, please visit this https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html 

Key Market Insights

Over 90 players, located across the globe, are presently offering non-viral drug delivery systems

About 55% of players engaged in this market are located in the North America, followed by those based in Europe and Asia. Further, very small and small companies represent ~70% of players in the non-viral drug delivery domain. In addition, 65% of the non-viral drug delivery systems providers are private organizations.

100 intracellular drug delivery systems are currently available in the market

Majority (71%) of the systems deliver biologics to the target site. Further, over 75% of the available systems use RNA as payload and conjugation as the most suitable type of interaction for delivering the payload intracellularly. In addition, nanoparticles emerged as the most preferred type of vehicle (45%) for delivery of payloads into the cell.

Till date, 1,140+ patents have been filed related to intracellular drug delivery technologies

The R&D activity focused on non-viral drug delivery systems is concentrated in North America and Europe. Further, nearly 55% of the total patents have been granted, followed by applications (over 40%). It is worth mentioning that most patented inventions are focused on development of nanoparticles and polymers.

Opportunity assessment framework is used to evaluate market potential of different intracellular non-viral drug delivery technologies

The framework categorizes technologies based on market demand, using various parameters, such as patent trends, publications, grants awarded and partnership deals. Utilizing the Kalbach Innovation Model, Ansoff Matrix and BCG Matrix, it assists domain experts in making sound decisions pertaining to the market potential of non-viral drug delivery systems.

Players based in North America are anticipated to capture over 40% of the market share by 2035

In terms of type of technology, nanoparticles-based drug delivery systems (54%) are expected to capture the highest share, followed by extracellular vesicles (16%). Based on therapeutic area, ~30% of the revenue share is likely to be driven by technologies intended for the treatment of infectious diseases.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market/request-sample.html 

Key Questions Answered

  • Who are the leading players engaged in the development of intracellular drug delivery technologies?
  • Which partnership models are commonly adopted by stakeholders developing non-viral drug delivery systems?
  • Which different types of molecules can be delivered using intracellular drug delivery technologies?
  • How is the intellectual property landscape related to intracellular drug delivery likely to evolve in the foreseen future?
  • How is the current and future market opportunity likely to be distributed across key market segments and geographical region?

The overall financial opportunity associated with the non-viral drug delivery systems market has been analyzed across the following segments:

  • Type of Payment Model
    • Upfront Payments
    • Milestone Payments
  • Type of Molecule Delivered
    • Small Molecules
    • Biologics
  • Type of Biologic Delivered
    • Antibodies
    • DNA
    • Proteins / Peptides
    • RNA
  • Type of Technology
    • Cell Penetrating Peptides
    • Extracellular Vesicles
    • Oligonucleotides
    • Nanoparticles
    • Polymers
  • Target Therapeutic Area
    • Cardiovascular Disorders
    • Genetic Disorders
    • Hepatic Disorders
    • Infectious Diseases
    • Neurological Disorders
    • Oncological Disorders
    • Other Disorders
  • Key Geographical Region
    • North America
    • Europe
    • Asia
    • Latin America
    • Middle East and North Africa
    • Rest of the World

The report also features inputs from eminent industry stakeholders, according to whom, the continuously growing demand for non-viral drug delivery systems is likely to drive the growth of the intracellular drug delivery market, in the foreseen future. The report includes detailed transcripts of discussions held with the following experts:

  • Anders Høgset (Chief Scientific Officer, PCI Biotech)
  • Melissa Wagner (Senior Director, Business Development, SRI International)
  • Tehila Ben-Moshe (Chief Executive Officer, Biond Biologics) and Itay Friedman (Chief Scientific Officer, Biond Biologics)
  • Don Haut (Chief Executive Officer, Carmine Therapeutics)
  • Thierry Bordet (Chief Scientific Officer, Eyevensys)
  • Maren Killackey (Senior Director, Investor Relations and Communications, Generation Bio)

The research includes profiles of key players (listed below) engaged in this domain; each profile features a brief overview of the company, details related to its recent developments (including funding and collaborations), financial performance (if available) and an informed future outlook.

  • Arcturus Therapeutics
  • Bio-Path
  • CureVac
  • Entos Pharmaceuticals
  • eTheRNA
  • Matinas BioPharma
  • MDimune
  • PCI Biotech

For additional details, please visit https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.htmlmailto: or email sales@rootsanalysis.com

You may also be interested in the following titles:

  1. Exosome Therapeutics Market: Industry Trends and Global Forecasts, 2022-2040
  2. mRNA Synthesis and Manufacturing Services Market (2nd Edition): Industry Trends and Global Forecasts, 2022-2035
  3. Cell Therapy Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035
  4. mRNA Therapeutics and mRNA Vaccines Market (2nd Edition): Industry Trends and Global Forecasts, 2022-2035
  5. Antiviral Drugs Market: Industry Trends and Global Forecasts, 2022-2035

Contact:

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.